Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1513 results found
2023 ∙ Rahmati, M. Yon, D. K. Lee, S. W. Butler, L. Koyanagi, A. Jacob, L. Shin, J. I. Smith, L.
Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis
Newborn Pregnant women COVID-19 Efficacy/effectiveness
Rating:
Moderate
2023 ∙ Li, G. Zhang, R. Song, B. Wang, C. Shen, Q. He, X. Cao, Y.
Effects of SARS-CoV-2 Vaccines on Sperm Quality: Systematic Review
Adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Law, M. Ho, S. S. H. Tsang, G. K. C. Ho, C. M. Y. Kwan, C. M. Yan, V. K. C. Yiu, H. H. E. Lai, F. T. T. Wong, I. C. K. Chan, E. W. Y.
Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Low
2023 ∙ Kuniduzi, Y. Chen, B. Zeng, J. Sun, X. Chen, T. Qian, X. Wang, J. Liang, F. Abuduxukuer, R. Yusufu, M. Xu, S. Zhang, X.
Efficacy and safety of a fourth dose of the COVID-19 vaccine in kidney transplant recipients: A systematic review and meta-analysis
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Taheri, S.
Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Joudeh, A. I. Lutf, A. Q. Mahdi, S. Tran, G.
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Wen, J. Liu, Q. Tang, D. He, J. Q.
Efficacy of BCG Vaccination against COVID-19: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Dou, D. Zhang, F. Deng, X. Ma, Y. Wang, S. Ji, X. Zhu, X. Wang, D. Zhang, S. Zhao, L.
Efficacy of COVID-19 vaccines in inflammatory bowel disease patients receiving anti-TNF therapy: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Meo, S. A. Aftab, S. Bayoumy, N. M. Meo, A. S.
Efficacy of Oxford-AstraZeneca (ChAdOx1 CoV-19) vaccine against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) cases, hospital admissions, type of variants, and deaths
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Yang, Z. R. Jiang, Y. W. Li, F. X. Liu, D. Lin, T. F. Zhao, Z. Y. Wei, C. Jin, Q. Y. Li, X. M. Jia, Y. X. Zhu, F. C. Yang, Z. Y. Sha, F. Feng, Z. J. Tang, J. L.
Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
Loading...